Dapagliflozin in Pulmonary Arterial Hypertension

Clinical trial NCT05179356 · COMPLETED

Trial details

NCT number: NCT05179356
Sponsor: Mads Ersbøll
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension Chronic Thromboembolic Pulmonary Hypertension

Start date: 2023-01-01
Primary completion: 2026-01-13
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.